Addressing Medical Challenges
699 articles related to "Addressing Medical Challenges"
-
Letter from Tajikistan by TB Nurse Cindy Gibb
Cindy Gibb is a nurse from New Zealand working in MSF’s groundbreaking treatment programme for children with drug-resistant tuberculosis in Tajikistan, Central Asia It is 8 am in Dushanbe,...
Web article – Last updated 11 October 2012
msfaccess.org/content/letter-tajikistan-tb-nurse-cindy-gibb -
‘Family TB’ in Tajikistan: MSF is first to treat children with MDR-TB
For the first time, children in Tajikistan with multi drug-resistant tuberculosis (MDR-TB) are receiving treatment for the life-threatening disease. Médecins Sans Frontières (MSF) has...
Web article – Last updated 11 October 2012
msfaccess.org/content/family-tb-tajikistan-msf-first-treat-children-mdr-tb -
TB: A Family Disease in Tajikistan
Nadira’s story: TB and the family tree Nadira and her two sons, aged three and four, live in a mountain village 40 km from Dushanbe. All three are being treated for tuberculosis (TB), two...
Web article – Last updated 11 October 2012
msfaccess.org/content/tb-family-disease-tajikistan -
Challenges and opportunities for the implementation of virological testing in resource-limited settings
Though the advantages of routine virological monitoring for patients on anti-retroviral therapy have been established, cost and complexity limit its full implementation. Monitoring is important...
In Medical Journals / Research Articles – Last updated 10 October 2012
msfaccess.org/content/challenges-and-opportunities-implementation-virological-testing-resource-limited-settings -
The Nobel Prize Acceptance Speech
Médecins Sans Frontières (MSF) was awarded the 1999 Nobel Peace Prize for its work with populations in danger. The following acceptance speech was delivered in Oslo, Norway on December...
Statements, Speeches, Letters – Last updated 10 December 1999
msfaccess.org/content/nobel-prize-acceptance-speech -
MSF Keynote Address at 2012 J. William Fulbright Prize for International Understanding
Thank you, Mark, for your tribute to MSF. It is fitting to have a patient turned medical advocate introduce us before this distinguished audience. The blending of direct medical humanitarian action...
Statements, Speeches, Letters – Last updated 09 October 2012
msfaccess.org/content/msf-keynote-address-2012-j-william-fulbright-prize-international-understanding -
MSF statement at WIPO General Assemblies on Agenda item 28(i) Standing Committee on the Law of Patents
Thanks Mr. Chairman. I am speaking on behalf of Médecins Sans Frontières International. MSF is an independent medical humanitarian organisation that works in over 65 countries around...
Statements, Speeches, Letters – Last updated 06 October 2012
msfaccess.org/content/msf-statement-wipo-general-assemblies-agenda-item-28i-standing-committee-law-patents -
MSF restates its anger and shock over abduction of aid works one year ago in Dadaab
The humanitarian organisation Médecins Sans Frontières (MSF) continues to fully support the families of Blanca Thiebaut and Montserrat Serra who were abducted from Kenya’s Dadaab...
Statements, Speeches, Letters – Last updated 10 October 2012
msfaccess.org/content/msf-restates-its-anger-and-shock-over-abduction-aid-works-one-year-ago-dadaab -
MSF launches online resource for challenging unwarranted drug patents
On 10-year anniversary of landmark Thai case, new ‘Patent Opposition Database’ aims to boost access to medicines in countries increasingly hit by high drug prices Geneva, 2 October 2012...
Press Release – Last updated 02 October 2012
msfaccess.org/about-us/media-room/press-releases/msf-launches-online-resource-challenging-unwarranted-drug-patents -
Preferred antiretroviral drugs for the next decade of scale up
Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission....
In Medical Journals / Research Articles – Last updated 27 September 2012
msfaccess.org/content/preferred-antiretroviral-drugs-next-decade-scale
↑ To top


